Medicus Pharma (MDCX) Institutional Ownership $2.57 +0.11 (+4.47%) As of 08/1/2025 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Medicus Pharma (NASDAQ:MDCX)Number ofInstitutional Buyers(last 12 months)6TotalInstitutional Inflows(last 12 months)$9.70MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$224.25K Get MDCX Insider Trade Alerts Want to know when executives and insiders are buying or selling Medicus Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data MDCX Institutional Buying and Selling by Quarter Medicus Pharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/1/2025May Hill Capital LLC35,622$107K0.0%N/A0.262% 7/31/2025 Interchange Capital Partners LLC1,586,871$4.75M1.1%-4.5%11.694% 7/17/2025 Guyasuta Investment Advisors Inc.76,911$230K0.0%N/A0.567% 7/11/2025 SeaCrest Wealth Management LLC46,624$139K0.0%N/A0.344% 5/15/2025Armistice Capital LLC1,266,000$4.71M0.1%N/A9.427% 5/5/2025Private Advisor Group LLC56,750$211K0.0%N/A0.423% 4/30/2025 Interchange Capital Partners LLC1,661,871$6.18M1.7%+14.0%12.388% 2/11/2025 Interchange Capital Partners LLC1,457,165$3.63M1.3%N/A13.434% (Data available from 1/1/2016 forward) MDCX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of MDCX shares? During the previous two years, the following institutional investors and hedge funds held shares of Medicus Pharma shares: Interchange Capital Partners LLC ($4.75M), Armistice Capital LLC ($4.71M), Guyasuta Investment Advisors Inc. ($230K), Private Advisor Group LLC ($211K), and SeaCrest Wealth Management LLC ($139K), May Hill Capital LLC ($107K).Learn more on Medicus Pharma's institutional investors. Which institutional investors have been buying Medicus Pharma's stock? The following institutional investors have purchased Medicus Pharma's stock in the last 24 months: Interchange Capital Partners LLC ($1.66M), Armistice Capital LLC ($1.27M), Guyasuta Investment Advisors Inc. ($76.91K), Private Advisor Group LLC ($56.75K), SeaCrest Wealth Management LLC ($46.62K), and May Hill Capital LLC ($35.62K). How much institutional buying is happening at Medicus Pharma? Institutional investors have bought a total of 3,143,778 shares in the last 24 months. This purchase volume represents approximately $9.70M in transactions. Which of Medicus Pharma's major shareholders have been selling company stock? The following institutional investors have sold Medicus Pharma stock in the last 24 months: Interchange Capital Partners LLC ($75K). How much institutional selling is happening at Medicus Pharma? Institutional investors have sold a total of 75,000 shares in the last 24 months. This volume of shares sold represents approximately $224.25K in transactions. Related Companies Enanta Pharmaceuticals Major Shareholders Lifevantage Major Shareholders C4 Therapeutics Major Shareholders Alpha Cognition Major Shareholders Lyell Immunopharma Major Shareholders Immuneering Major Shareholders Molecular Partners Major Shareholders Greenwich LifeSciences Major Shareholders Nkarta Major Shareholders Inhibikase Therapeutics Major Shareholders This page (NASDAQ:MDCX) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medicus Pharma Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Medicus Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MDCX Stock Alerts